Quarantine Storage
Secure, GxP-Compliant Storage for Products
Awaiting Release or Inspection
Awaiting Release or Inspection
Problem:
Unreleased or undocumented products must be securely held until regulatory clearance is granted.
Solution
COREX offers GxP-compliant quarantine storage with full monitoring and segregation to maintain control until release or disposal.
What We Offer:
Our facilities support the temporary storage of pharmaceutical goods under quarantine conditions:
GxP-Compliant Quarantine Zones
Clearly segregated, access-controlled areas for investigational products and restricted goods.
Validated Temperature Ranges
Storage across +15°C to +25°C, +2°C to +8°C, -20°C, -80°C, and LN2 environments.
Secure Holding for Unreleased or Imported Goods
Including materials pending customs clearance, batch release, or quality testing.
Regulatory Documentation Support
Full tracking, temperature logging, and audit-ready records during the quarantine period.
Relabelling, Inspection, & Onward Release
Optional services for preparing products for further distribution or destruction.
COREX Global Network
Ensuring seamless clinical supply solutions with local expertise and global reach.